BET inhibitors like JQ1, and related small molecules that interfere with SEs, have been shown to be effective in animal models of atherosclerosis, AAA56, inflammatory renal disease57, pulmonary hypertension58, carotid intimal hyperplasia59 and heart failure60, and in clinical trials for certain cancers61. The gene discussed is DNER; the disease is atherosclerosis.